Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 128Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Lymphoma, Non-Hodgkin 83Lymphoma, Follicular 76Lymphoma, Large B-Cell, Diffuse 71Leukemia 60Lymphoma, Mantle-Cell 51Burkitt Lymphoma 48Hodgkin Disease 44Leukemia, Myeloid, Acute 42Lymphoma, B-Cell, Marginal Zone 41Lymphoma, B-Cell 40Recurrence 38Lymphoma, T-Cell, Cutaneous 27Mycosis Fungoides 26Myelodysplastic Syndromes 25Waldenstrom Macroglobulinemia 24Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24Multiple Myeloma 21Lymphoma, Large-Cell, Immunoblastic 21Lymphoma, Large-Cell, Anaplastic 21Sezary Syndrome 19Neoplasms 19Hematologic Neoplasms 18Myeloproliferative Disorders 17Lymphoma, Extranodal NK-T-Cell 16Leukemia, Myelomonocytic, Chronic 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Leukemia, Biphenotypic, Acute 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Meibomian Gland Dysfunction × Lymphoid × Clear all
NCT01692665 2014-02-19

Changes of Keratometric Value and Ocular Aberration After Treatment of Meibomian Gland Dysfunction

Yonsei University

Withdrawn
Lymphoid

Meibomian Gland Dysfunction, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡